Company Quick10K Filing
GlaxoSmithKline
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 5,379 $200,316
20-F 2019-03-15 Annual: 2018-12-31
20-F 2018-03-16 Annual: 2017-12-31
20-F 2017-03-17 Annual: 2016-12-31
20-F 2016-03-18 Annual: 2015-12-31
20-F 2014-02-28 Annual: 2013-12-31
20-F 2013-03-08 Annual: 2012-12-31
20-F 2012-03-13 Annual: 2011-12-31
20-F 2011-03-04 Annual: 2010-12-31
20-F 2010-03-01 Annual: 2009-12-31

GlaxoSmithKline Financials

GSK Metrics, Comps, Filings

Annual | Quarterly

Business

- "Head Office and Registered Office" on the outside back cover; and

- "Note 38 - Acquisitions and disposals" on pages 191 to 193

of the GSK Annual Report 2018 is incorporated herein by reference.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Johnson & Johnson (JNJ) 379,441 67% 14.8 11% 155,117 94,332 81,325 54,220 16,332 26,618 392,764
Pfizer (PFE) 249,913 80% 17.8 8% 156,199 96,274 53,657 42,879 12,674 16,080 286,383
Merck (MRK) 217,623 70% 14.1 11% 83,965 56,330 44,368 31,007 9,370 16,585 233,734
GlaxoSmithKline (GSK) 200,316 0% 58,066 54,394 0 0 0 0 225,704
Novartis (NVS) 197,050 0% 145,563 66,871 0 0 0 0 193,929
Abbott (ABT) 149,087 57% 22.9 4% 68,427 36,741 30,935 17,651 2,895 7,217 164,940
Eli Lilly (LLY) 106,241 77% 11.8 20% 38,666 35,809 23,229 17,810 7,843 9,937 117,668
AbbVie (ABBV) 100,912 77% 18.0 7% 57,142 65,708 32,624 25,254 4,118 7,085 127,359
Beigene (BGNE) 98,573 88% -152.1 -31% 2,150 579 434 383 -664 -642 97,723
Bristol Myers Squibb (BMY) 73,829 53% 8.4 11% 55,163 39,012 23,857 12,640 6,226 8,365 69,858
Celgene (CELG) 67,154 96% 10.4 13% 39,183 29,132 16,354 15,736 5,271 7,702 79,730
GW Pharmaceuticals (GWPH) 64,239 88% -1,554.6 -6% 843 114 114 100 -50 -41 63,656
Allergan (AGN) 54,767 85% 80.8 -4% 123,846 38,273 15,678 13,341 -5,356 939 75,841
Zoetis (ZTS) 54,569 67% 25.9 13% 10,986 8,575 6,046 4,046 1,375 2,291 59,314
Sanofi (SNY) 52,845 0% 111,408 0 0 0 0 52,184
Vertex Pharmaceuticals (VRTX) 46,842 87% 16.9 33% 7,033 1,964 3,454 2,990 2,355 2,569 43,540
Regeneron Pharmaceuticals (REGN) 35,984 0% 15.2 16% 13,174 3,418 7,237 0 2,069 2,295 34,925
Alexion Pharmaceuticals (ALXN) 28,246 71% 15.7 9% 14,568 4,404 4,499 3,191 1,334 1,835 28,827
Biomarin Pharmaceutical (BMRN) 15,774 79% 680.7 -3% 4,393 1,432 1,533 1,213 -110 24 16,336
Elanco Animal Health (ELAN) 12,085 52% 30.6 2% 8,857 3,591 3,073 1,591 144 460 14,098

Balance Sheet ($MM)2018-12-31
Cash569
Accounts Receivable
Inventory
PP&E
Assets58,066
Accounts Payable
Long-Term Debt25,957
Liabilities54,394
Stockholders' Equity
Income Statement ($MM)2018-12-31
Revenue30,821
Cost of Revenue10,241
Gross Profit20,580
R&D3,893
SG&A9,915
Tax
Net Income4,046
Cash Flow ($MM)2018-12-31
Cash Operating
Cash Investing
Cash Financing